Every material Form 8-K Rayonier filed with the SEC in 2025, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Rayonier reported third quarter 2025 net income attributable to Rayonier of $43.2 million ($0.28 per share) on revenues of $177.5 million, up from $28.8 million ($0.19 per share) on $124.1 million a year earlier. The company now expects full-year Adjusted EBITDA at or above the higher end of its prior guidance range, though it expects Southern Timber to fall modestly below its range and Pacific Northwest Timber toward the lower end.
Q3 pro forma net income was $50.2 million ($0.32 per share) versus $11.1 million ($0.07) a year earlier; Adjusted EBITDA was $114.3 million versus $57.2 million.
Real Estate Adjusted EBITDA was $73.8 million, and the company expects full-year Real Estate Adjusted EBITDA to exceed the high end of its prior range.
Q4 outlook: net income attributable to Rayonier of $13 to $17 million, EPS of $0.08 to $0.11, and Adjusted EBITDA of $50 to $60 million.
Quarter-end cash balance was $919.6 million; the company repurchased 1,226,384 shares for $30.1 million and expects the PotlatchDeltic merger to close in late first quarter or early second quarter 2026.
Rayonier agreed on October 13, 2025 to combine with PotlatchDeltic in an all-stock merger of equals, in which each PotlatchDeltic share would convert into 1.7339 Rayonier common shares. Rayonier shareholders would own about 54% of the combined company and PotlatchDeltic shareholders about 46%, so the deal changes ownership and governance for both companies' shareholders, and closing requires shareholder and regulatory approvals and is expected in late first quarter or early second quarter of 2026.
Exchange ratio of 1.7339 Rayonier shares per PotlatchDeltic share, an implied price of $44.11 per PotlatchDeltic share and a premium of 8.25% to its October 10, 2025 closing price
Rayonier shareholders would own about 54% and PotlatchDeltic shareholders about 46% of the combined company
Rayonier pays a termination fee of up to $159 million, and PotlatchDeltic pays up to $138 million, under certain circumstances
Rayonier declared a one-time special dividend of $1.40 per share, payable December 12, 2025 to holders of record on October 24, 2025; PotlatchDeltic holders receive an adjusted exchange ratio and cash component to offset it
Rayonier and its subsidiaries entered into an amended and restated credit agreement on August 15, 2025, covering $800 million of senior unsecured facilities. The revolving credit facility's maturity was extended to August 15, 2030, while the three term loan maturities were unchanged. The filing describes refinancing terms rather than a change in reported results, so its direct effect on shareholders is limited to the revised borrowing terms.
Facilities total $800 million: a $200 million revolving credit facility and three $200 million term loans
Revolving credit facility maturity extended to August 15, 2030; term loan maturities unchanged (April 1, 2028; April 28, 2026; June 1, 2029)
Borrowers may increase revolving commitments by up to $100 million, subject to a leverage ratio limit of 52.5%
Agreement includes leverage and interest coverage financial covenants; CoBank, ACB is administrative agent
Rayonier reported second quarter 2025 net income attributable to Rayonier of $408.7 million ($2.63 per share), driven by a $404.4 million gain on the sale of its New Zealand joint venture interest. Excluding that gain and related items, pro forma net income was $9.6 million ($0.06 per share), up from a pro forma loss of $2.6 million a year earlier, and the company said it is on track for full-year Adjusted EBITDA and pro forma EPS within its prior guidance range.
Q2 revenues were $106.5 million versus $99.6 million in the prior year quarter; Adjusted EBITDA was $44.9 million versus $33.3 million.
Pro forma net income was $9.6 million ($0.06 per share) versus a pro forma loss of $2.6 million ($0.02 per share) a year earlier.
Third quarter guidance: net income attributable to Rayonier of $29 to $44 million, EPS of $0.18 to $0.28, and Adjusted EBITDA of $80 to $100 million.
The company repurchased 1.5 million shares for $34.9 million and had $262.4 million remaining on its repurchase authorization as of June 30, 2025.
Rayonier reported a first-quarter 2025 net loss attributable to the company of $3.4 million, or $0.02 per share, on revenues of $82.9 million, compared with net income of $1.4 million on $113.7 million a year earlier. The company also revised full-year 2025 guidance to move its New Zealand operations to discontinued operations, with Adjusted EBITDA guidance of $215 to $235 million, which it said is generally in line with prior guidance excluding New Zealand.
Q1 2025 net loss attributable to Rayonier was $3.4 million ($0.02 per share), versus net income of $1.4 million ($0.01 per share) in Q1 2024
Q1 Adjusted EBITDA was $27.1 million, down from $44.6 million a year earlier
Full-year 2025 Adjusted EBITDA guidance is $215 to $235 million; net income guidance is $424 to $458 million, including the anticipated gain on the New Zealand sale
Second-quarter 2025 guidance: net income attributable to Rayonier of $3 to $8 million and Adjusted EBITDA of $30 to $40 million
Rayonier's subsidiaries agreed on March 9, 2025 to sell their entire 77% interest in the New Zealand joint venture to a vehicle formed by Ents LP, an investment fund managed by The Rohatyn Group, for $710 million, subject to adjustments. Rayonier says the sale is modestly accretive to pro forma CAD per share and lowers pro forma net debt to Adjusted EBITDA to about 0.3x, but the filing's pro forma table also shows Adjusted EBITDA falling from $298.8 million to $245.1 million. Closing is expected in 2025, subject to regulatory approvals.
Purchase price of $710 million for the 77% interest, implying an enterprise value of $922 million for the joint venture
Company expects the sale to be modestly accretive to pro forma CAD per share, with a 1.3% accretion in its pro forma table
Pro forma Adjusted EBITDA is shown at $245.1 million, versus $298.8 million in 2024 before the sale
Closing requires approvals including antitrust in China and South Korea; either party may terminate if not closed by December 9, 2025
Rayonier reported fourth quarter 2024 net income attributable to Rayonier of $327.1 million ($2.15 per share), up from $126.9 million a year earlier, with $291.1 million of that income from Large Dispositions. Adjusted EBITDA rose 23% to $115.1 million, but the company's 2025 Adjusted EBITDA guidance of $270-300 million is below the $298.8 million reported for full-year 2024, and its 2025 guidance excludes any further asset sales.
Q4 2024 net income attributable to Rayonier was $327.1 million ($2.15 per share), versus $126.9 million ($0.85 per share) in Q4 2023
Q4 2024 Adjusted EBITDA was $115.1 million, versus $93.7 million in the prior year quarter
2025 guidance: net income attributable to Rayonier of $79-100 million, EPS of $0.51-0.64, and Adjusted EBITDA of $270-300 million, versus $298.8 million for full-year 2024
Real Estate segment Adjusted EBITDA is guided to $86-96 million for 2025, down from the 'exceptionally strong' 2024 results
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Rayonier filing is on SEC EDGAR ↗. 8-K briefs of other companies →